FINWIRES · TerminalLIVE
FINWIRES

Research Alert: Organon To Be Acquired By Sun Pharma In A Surprise Deal Announcement Today

By

-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:

In a surprise announcement today, Sun Pharma, India's largest drugmaker and the fourth-largest specialty generic pharmaceutical firm globally, announced its agreement to acquire Organon for $14.00 per share in an all-cash deal valued at $11.75B enterprise value. The transaction, slated to close in early 2027, is expected to create a top 25 global pharmaceutical firn with ~$12.4B in combined revenue, making Sun Pharma a top three player in women's health, the seventh largest biosimilars company globally. We think this acquisition makes strategic sense as Organon has been facing performance and governance issues in the past year after an internal investigation found improper wholesale practices in the U.S. related to Organon's key contraceptive Nexplanon and the abrupt departure of the former CEO K. Ali. Shares of OGN jumped by 17% today after the news. We raise our target to $14.00 from $7.00, based on a P/E of 3.8x our 2027 EPS estimate.We keep our 2026 EPS estimate at $3.62 and our 2027 EPS estimate at $3.71.

Related Articles

Treasury

US Treasury Closing Levels

3:00 Monday vs 3:00 Friday2yr 100-04 vs 100-05; 3.799% vs 3.744%5yr 99-21+ vs 99-25+; 3.947% vs 3.918%10yr 98-10+ vs 98-17; 4.335% vs 4.308%30yr 96-31+ vs 97-14; 4.941% vs 4.914%2/10 53.307 bps vs 53.245 bps5/30 99.249 bps vs 99.402 bps

Australia

Booking Offers Compelling Entry Point as Focus Shifts Back to Fundamentals, Oppenheimer Says

Booking (BKNG) is offering a compelling entry point for patient investors as focus shifts back to fundamentals amid geopolitical tensions, Oppenheimer said, with analysts highlighting attractive valuation and resilient travel demand supporting the outlook.The brokerage said in a Sunday note that shares have underperformed peers since the Iran conflict, reflecting higher Middle East exposure and Asia/Europe sensitivity to oil supply.Oppenheimer said airline commentary and third-party traffic checks suggest solid underlying demand, pointing to upside versus Q1 nights guidance of more than 7%. However, geopolitical tensions could still weigh on the outlook relative to underlying trends.Booking has also outperformed the S&P since OpenAI paused retail instant checkout, supporting the view that large travel platforms remain central in the evolving AI-driven travel ecosystem, according to the note.The company is scheduled to report its Q1 results Tuesday after market close.Oppenheimer maintained its outperform rating on the stock with a price target of $240.Price: $179.23, Change: $-1.05, Percent Change: -0.58%

$BKNG
Commodities

US Oil Update: Crude Gains 2% on Stalled US-Iran Talks, Hormuz Blockade

Crude oil futures climbed in midday trading on Monday as efforts to resume US-Iran peace talks appear to have stalled, with escalating tensions over the Strait of Hormuz keeping prices elevated.Front-month West Texas Intermediate crude futures gained 2.31% to $96.58 per barrel, while Brent futures were up 3.28% to $108.85/bbl.Saxo Bank strategists said crude is set to grind higher as Hormuz remains effectively closed, extending disruptions across the Middle East and tightening the availability of critical commodities.On Monday, Iran's Foreign Minister Abbas Araqchi reportedly said that Tehran was reviewing President Trump's request for negotiations. Araghchi also met Russian President Vladimir Putin in Moscow on Monday to discuss the conflict as negotiations between the sides appear to have stalled.His visit follows a weekend of talks in Pakistan and Oman, which have both acted as mediators in the negotiations between Tehran and Washington.Putin reportedly told Araghchi that Russia would "do everything that serves your interests, the interests of all the people of the region, so that peace can be achieved as soon as possible"."Brent crude trades at a three-week high as efforts to revive peace talks have stalled, with an Iranian proposal reportedly calling for nuclear negotiations to be postponed to a later stage," Saxo Bank analysts said.Meanwhile, Trump canceled a planned trip by US peace envoy Steve Witkoff and Jared Kushner to Pakistan as the Iranian leadership reiterates that Tehran won't negotiate if it's being threatened. President Masoud Pezeshkian said his country won't enter "imposed negotiations under threats or blockade," according to media reports.ING strategists said the lack of progress means the market is tightening every day, requiring oil prices to reprice at higher levels, as there is little alternative to fill about 13 million b/d of the shortfall.The US-Israeli alliance and Iran have mostly observed a ceasefire since early April, but the double blockade of the Hormuz has ground vessel traffic through the strategic waterway to near zero."With US sanctions tightening and military interceptions continuing, markets remain highly sensitive to any signs of diplomatic progress or further escalation," Soojin Kim, research analyst at MUFG, said.Over the weekend, the US Central Command said its forces were continuing to implement the blockade, preventing vessels from entering or leaving Iranian waters. "American forces have directed 38 ships to turn around, or return to port," Centcom said in a post on X Sunday.